TransMedics Group stock kpis
Want to see TMDX full AI Analyst Report?
Revenue by Type
TransMedics Group reported revenue by type of $203.00M in Q3 2026, up 6.9% from Q2 2026 and up 41.1% year over year. This is the highest value since 2022.
Shows how much revenue comes from device sales, consumables/disposables, and services. For TransMedics, a larger share of recurring consumables and service revenue signals steadier growth and less dependence on one-time system sales, while reliance on capital equipment can make results lumpy and more sensitive to hospital purchasing cycles.
TransMedics’ growth is increasingly service‑led: services have scaled into a material share of revenue, fueling record top‑line momentum and more recurring, logistics-driven dollars while product sales grow more unevenly. That mix helped lift revenue guidance but explains the YoY margin pressure management flagged; PAD consolidation and heavy R&D investments will likely keep near-term margins muted even as the company bets on organic momentum and multi‑year scale toward its >$2B revenue goal.
TMDX Revenue by Type
| Period | Product | Service | Total |
|---|---|---|---|
| Q3 2026Sep 30, 2026 | $113.42M | $89.59M | $203.00M |
| Q2 2026Jun 30, 2026 | $111.16M | $78.79M | $189.95M |
| Q1 2026Mar 31, 2026 | $107.97M | $65.96M | $173.93M |
| Q4 2025Dec 31, 2025 | $100.39M | $60.37M | $160.76M |
| Q3 2025Sep 30, 2025 | $87.68M | $56.15M | $143.82M |
| Q2 2025Jun 30, 2025 | $96.10M | $61.27M | $157.37M |
| Q1 2025Mar 31, 2025 | $88.23M | $55.30M | $143.54M |
| Q4 2024Dec 31, 2024 | $74.95M | $46.68M | $121.62M |
| Q3 2024Sep 30, 2024 | $65.86M | $42.90M | $108.76M |
| Q2 2024Jun 30, 2024 | $71.73M | $42.57M | $114.31M |
| Q1 2024Mar 31, 2024 | $61.33M | $35.52M | $96.85M |
| Q4 2023Dec 31, 2023 | $51.87M | $29.30M | $81.17M |
| Q3 2023Sep 30, 2023 | $47.74M | $18.69M | $66.43M |
| Q2 2023Jun 30, 2023 | $42.46M | $10.00M | $52.47M |
| Q1 2023Mar 31, 2023 | $33.99M | $7.56M | $41.55M |
| Q4 2022Dec 31, 2022 | $25.07M | $6.30M | $31.38M |
| Q3 2022Sep 30, 2022 | $21.30M | $4.38M | $25.68M |
| Q2 2022Jun 30, 2022 | $17.92M | $2.60M | $20.52M |
| Q1 2022Mar 31, 2022 | $14.94M | $941.00K | $15.88M |

